The use of an anti-peristaltic agent (e.g. glucagon, butyl-scopolamine), unless contraindicated (e.g. diabetes or phaeochromocytoma), is the most efficient way to limit bowel motion artefact (Fig. 2) (LE4) [52]. The gene discussed is GCG; the disease is diabetes mellitus.